Panacea Biotec

Market Cap: Small Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE922B01023
NSEID: PANACEABIO
BSEID: 531349

INR

356.30

10.5 (3.04%)

BSENSE

Dec 19

BSE+NSE Vol: 36.13 k

{
  "main_header": {
    "sid": 622974,
    "name": "Panacea Biotec",
    "stock_name": "Panacea Biotec",
    "full_name": "Panacea Biotec Ltd",
    "name_url": "stocks-analysis/panacea-biotec",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "356.30",
    "chg": 10.5,
    "chgp": "3.04%",
    "dir": 1,
    "prev_price": "345.80",
    "mcapval": "2,209.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 531349,
    "symbol": "PANACEABIO",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE922B01023",
    "curr_date": "Dec 19",
    "curr_time": "",
    "bse_nse_vol": "36.13 k",
    "exc_status": "Active",
    "traded_date": "Dec 19, 2025",
    "traded_date_str": "2025 12 19",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/panacea-biotec-622974-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Panacea Biotec Sees Revision in Market Evaluation Amidst Challenging Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/panacea-biotec-downgraded-to-strong-sell-amid-deteriorating-fundamentals-3764506",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/PanaceaBiotec_mojoScore_3764506.png",
        "date": "2025-12-20 10:10:15",
        "description": "Panacea Biotec has experienced a revision in its market evaluation reflecting a more cautious outlook, driven by recent financial results and shifts in key assessment parameters. The pharmaceutical and biotechnology company’s current market capitalisation remains in the small-cap category, with recent trading activity showing a modest intraday gain of 3.04% despite broader concerns."
      },
      {
        "title": "Why is Panacea Biotec falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-panacea-biotec-fallingrising-3757789",
        "imagepath": "",
        "date": "2025-12-13 01:11:27",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Short-Term Price Movement and Market Context</strong></p>\n<p>Panacea Biotec’s stock price demonstrated a strong intraday performance, reaching a high of ₹370, representing an 11.73% increase from previous levels. This surge came after a period of two consecutive days of falling prices, signalling a potential trend reversal. The stock traded within a wide range of ₹35, indicating heightened volatility and active trading interest. Despite this, the weighted average price suggests that a larger volume of shares exchanged hands closer to the lower end of the day’s price range, hinting at some selling pressure amid the rally.</p>\n<p>From a technical perspective, the stock is currently trading above its 5-day and 20-day moving averages, which often signals short-term bullish momentum. However, it ..."
      },
      {
        "title": "Panacea Biotec Hits Intraday High with Strong 7.9% Surge in Trading",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/panacea-biotec-hits-intraday-high-with-705-surge-on-12-dec-2025-3757494",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/PanaceaBiotec_priceRelatedfactors_3757494.png",
        "date": "2025-12-12 13:46:24",
        "description": "Panacea Biotec recorded a robust intraday performance on 12 Dec 2025, touching a day’s high of Rs 357.45, reflecting a 7.94% rise during trading hours. This surge outpaced the Pharmaceuticals & Biotechnology sector and the broader market indices, marking a notable rebound after two days of declines."
      },
      {
        "title": "Panacea Biotec Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/panacea-biotec-technical-momentum-shifts-amid-bearish-signals-3740124",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/PanaceaBiotec_technicaldot_3740124.png",
        "date": "2025-12-02 08:07:09",
        "description": "Panacea Biotec, a key player in the Pharmaceuticals & Biotechnology sector, is currently exhibiting a shift in its technical momentum, reflecting a complex interplay of bearish and mildly bullish signals across various timeframes. Recent market data and technical indicators reveal nuanced changes in price action and momentum, warranting a closer examination of the stock’s near-term outlook."
      },
      {
        "title": "Panacea Biotec Sees Revision in Market Assessment Amidst Challenging Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/panacea-biotec-downgraded-to-strong-sell-amid-deteriorating-fundamentals-3736882",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/PanaceaBiotec_mojoScore_3736882.png",
        "date": "2025-11-29 17:52:10",
        "description": "Panacea Biotec has experienced a revision in its market evaluation reflecting ongoing challenges in its financial and operational performance. The pharmaceutical and biotechnology company’s recent assessment highlights concerns across multiple analytical parameters, signalling a cautious outlook for investors amid subdued returns and persistent losses."
      },
      {
        "title": "Panacea Biotec Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/panacea-biotec-technical-momentum-shifts-amid-mixed-market-signals-3732418",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/PanaceaBiotec_technicaldot_3732418.png",
        "date": "2025-11-27 08:04:19",
        "description": "Panacea Biotec has experienced a notable shift in its technical momentum, reflecting a complex interplay of market indicators that suggest a transition from bearish to mildly bearish trends. Recent price movements and technical signals provide a nuanced view of the stock’s current position within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Panacea Biotec Hits Intraday High with Strong Trading Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/panacea-biotec-hits-intraday-high-with-strong-751-surge-on-26-nov-2025-3731540",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/PanaceaBiotec_priceRelatedfactors_3731540.png",
        "date": "2025-11-26 14:07:45",
        "description": "Panacea Biotec demonstrated robust intraday performance today, surging to an intraday high of Rs 373, marking an 8.41% rise. This notable uptick outpaced the Pharmaceuticals & Biotechnology sector and reflected heightened trading activity amid a broadly positive market backdrop."
      },
      {
        "title": "Panacea Biotec Technical Momentum Shifts Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/panacea-biotec-technical-momentum-shifts-amid-bearish-sentiment-3730196",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/PanaceaBiotec_technicaldot_3730196.png",
        "date": "2025-11-26 08:04:43",
        "description": "Panacea Biotec, a key player in the Pharmaceuticals & Biotechnology sector, has experienced notable shifts in its technical momentum, reflecting evolving market dynamics and investor sentiment. Recent assessment changes highlight a transition in price momentum and technical indicators, underscoring the challenges faced by the stock amid broader market fluctuations."
      },
      {
        "title": "Panacea Biotec Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/panacea-biotec-technical-momentum-shifts-amid-mixed-market-signals-3727523",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/PanaceaBiotec_technicaldot_3727523.png",
        "date": "2025-11-25 08:08:04",
        "description": "Panacea Biotec, a key player in the Pharmaceuticals & Biotechnology sector, is exhibiting a nuanced shift in its technical momentum as recent evaluation adjustments highlight a transition from bearish to mildly bearish trends. The stock’s price action, supported by a range of technical indicators including MACD, RSI, and moving averages, reveals a complex market assessment that investors should carefully analyse amid broader sector dynamics."
      }
    ],
    "total": 193,
    "sid": "622974",
    "stock_news_url": "https://www.marketsmojo.com/news/panacea-biotec-622974"
  },
  "announcements": [
    {
      "caption": "Appointment of Company Secretary and Compliance Officer",
      "datetime": "15-Dec-2025",
      "details": "We would like to inform you that Mr. Ankit Jain (who is currently acting as Assistant General Manager - Legal of the Companys wholly owned subsidiary Panacea Biotec Pharma Ltd.) has been appointed as Company Secretary and Compliance Officer designated as General Manager - Legal & Company Secretary of the Company under the category of KMP and SMP with effect from December 16 2025 based on the recommendation and approval of the Nomination & Remuneration Committee.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Cessation",
      "datetime": "15-Dec-2025",
      "details": "We would like to inform you that Mr. Vinod Goel (who is currently acting as Group CFO and Head Legal & Company Secretary as well as Compliance Officer of the Company) shall cease to be Company Secretary and Compliance Officer of the Company w.e.f. December 15 2025 consequent to his appointment as Chief Financial Officer and Head Legal & Corporate Governance of the Company w.e.f. December 16 2025.",
      "source": "BSE"
    },
    {
      "caption": "Authorization Of Key Managerial Personnel For The Purpose Of Determining Materiality Of An Event Or Information &Making Disclosures To The Stock Exchange(S) Under The SEBI LODR Regulations",
      "datetime": "15-Dec-2025",
      "details": "We would like to inform you that the Board of Directors in its meeting held today i.e. December 15 2025 approved revised Policy for determining Materiality of Events / Information and authorised few Key Managerial Personnel for the purpose of determining materiality of an event or information & making disclosures to stock exchanges under the SEBI LODR Regulations.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Panacea Biotec Ltd has declared <strong>75%</strong> dividend, ex-date: 19 Sep 11",
          "dt": "2011-09-19",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Panacea Biotec Sees Revision in Market Evaluation Amidst Challenging Financials

2025-12-20 10:10:15

Panacea Biotec has experienced a revision in its market evaluation reflecting a more cautious outlook, driven by recent financial results and shifts in key assessment parameters. The pharmaceutical and biotechnology company’s current market capitalisation remains in the small-cap category, with recent trading activity showing a modest intraday gain of 3.04% despite broader concerns.

Why is Panacea Biotec falling/rising?

2025-12-13 01:11:27

Short-Term Price Movement and Market Context

Panacea Biotec’s stock price demonstrated a strong intraday performance, reaching a high of ₹370, representing an 11.73% increase from previous levels. This surge came after a period of two consecutive days of falling prices, signalling a potential trend reversal. The stock traded within a wide range of ₹35, indicating heightened volatility and active trading interest. Despite this, the weighted average price suggests that a larger volume of shares exchanged hands closer to the lower end of the day’s price range, hinting at some selling pressure amid the rally.

From a technical perspective, the stock is currently trading above its 5-day and 20-day moving averages, which often signals short-term bullish momentum. However, it ...

Panacea Biotec Hits Intraday High with Strong 7.9% Surge in Trading

2025-12-12 13:46:24

Panacea Biotec recorded a robust intraday performance on 12 Dec 2025, touching a day’s high of Rs 357.45, reflecting a 7.94% rise during trading hours. This surge outpaced the Pharmaceuticals & Biotechnology sector and the broader market indices, marking a notable rebound after two days of declines.

Panacea Biotec Technical Momentum Shifts Amid Mixed Market Signals

2025-12-02 08:07:09

Panacea Biotec, a key player in the Pharmaceuticals & Biotechnology sector, is currently exhibiting a shift in its technical momentum, reflecting a complex interplay of bearish and mildly bullish signals across various timeframes. Recent market data and technical indicators reveal nuanced changes in price action and momentum, warranting a closer examination of the stock’s near-term outlook.

Panacea Biotec Sees Revision in Market Assessment Amidst Challenging Financials

2025-11-29 17:52:10

Panacea Biotec has experienced a revision in its market evaluation reflecting ongoing challenges in its financial and operational performance. The pharmaceutical and biotechnology company’s recent assessment highlights concerns across multiple analytical parameters, signalling a cautious outlook for investors amid subdued returns and persistent losses.

Panacea Biotec Technical Momentum Shifts Amid Mixed Market Signals

2025-11-27 08:04:19

Panacea Biotec has experienced a notable shift in its technical momentum, reflecting a complex interplay of market indicators that suggest a transition from bearish to mildly bearish trends. Recent price movements and technical signals provide a nuanced view of the stock’s current position within the Pharmaceuticals & Biotechnology sector.

Panacea Biotec Hits Intraday High with Strong Trading Momentum

2025-11-26 14:07:45

Panacea Biotec demonstrated robust intraday performance today, surging to an intraday high of Rs 373, marking an 8.41% rise. This notable uptick outpaced the Pharmaceuticals & Biotechnology sector and reflected heightened trading activity amid a broadly positive market backdrop.

Panacea Biotec Technical Momentum Shifts Amid Market Volatility

2025-11-26 08:04:43

Panacea Biotec, a key player in the Pharmaceuticals & Biotechnology sector, has experienced notable shifts in its technical momentum, reflecting evolving market dynamics and investor sentiment. Recent assessment changes highlight a transition in price momentum and technical indicators, underscoring the challenges faced by the stock amid broader market fluctuations.

Panacea Biotec Technical Momentum Shifts Amid Mixed Market Signals

2025-11-25 08:08:04

Panacea Biotec, a key player in the Pharmaceuticals & Biotechnology sector, is exhibiting a nuanced shift in its technical momentum as recent evaluation adjustments highlight a transition from bearish to mildly bearish trends. The stock’s price action, supported by a range of technical indicators including MACD, RSI, and moving averages, reveals a complex market assessment that investors should carefully analyse amid broader sector dynamics.

View All News

Announcement

Appointment of Company Secretary and Compliance Officer

15-Dec-2025 | Source : BSE

We would like to inform you that Mr. Ankit Jain (who is currently acting as Assistant General Manager - Legal of the Companys wholly owned subsidiary Panacea Biotec Pharma Ltd.) has been appointed as Company Secretary and Compliance Officer designated as General Manager - Legal & Company Secretary of the Company under the category of KMP and SMP with effect from December 16 2025 based on the recommendation and approval of the Nomination & Remuneration Committee.

Announcement under Regulation 30 (LODR)-Cessation

15-Dec-2025 | Source : BSE

We would like to inform you that Mr. Vinod Goel (who is currently acting as Group CFO and Head Legal & Company Secretary as well as Compliance Officer of the Company) shall cease to be Company Secretary and Compliance Officer of the Company w.e.f. December 15 2025 consequent to his appointment as Chief Financial Officer and Head Legal & Corporate Governance of the Company w.e.f. December 16 2025.

Authorization Of Key Managerial Personnel For The Purpose Of Determining Materiality Of An Event Or Information &Making Disclosures To The Stock Exchange(S) Under The SEBI LODR Regulations

15-Dec-2025 | Source : BSE

We would like to inform you that the Board of Directors in its meeting held today i.e. December 15 2025 approved revised Policy for determining Materiality of Events / Information and authorised few Key Managerial Personnel for the purpose of determining materiality of an event or information & making disclosures to stock exchanges under the SEBI LODR Regulations.